| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000016166 |
| Receipt No. | R000018762 |
| Official scientific title of the study | The effect of telmisartan in hypertensive patients with obstructive sleep apnea |
| Date of disclosure of the study information | 2015/01/09 |
| Last modified on | 2018/07/18 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | The effect of telmisartan in hypertensive patients with obstructive sleep apnea | |
| Title of the study (Brief title) | The effect of telmisartan in hypertensive patients with obstructive sleep apnea | |
| Region |
|
|
| Condition | |||
| Condition | Hypertension | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To assess the effect of telmisartan in autonomic function in the hypertensive patients with obstructive sleep apnea who is unavailable on continuous positive airway pressure |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | autonomic function |
| Key secondary outcomes | 1)polysomnography
2)blood pressure, pulse rate 3)index of oxidative stress |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | 20mg, 40mg or 80mg of telmisartan | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)Patients with obstructive sleep apnea
2)The untreated hypertensive patients with BP beyond 140/90mmHg, or the uncontrolled hypertensive patients treated with single antihypertensive drugs other than RAS blockades (renin inhibitor, ACE inhibitor, ARB, aldosterone blocker). 3)Patients unavailable on continuous positive airway pressure for any reason. |
|||
| Key exclusion criteria | 1)The subjects who have past medical history of hypersensitivity to telmisartan
2)The subjects during pregnancy or lactation 3)The subjects found offensive by attending physicians for this research |
|||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | Norihisa Ito |
| Organization | Osaka university graduate school of medicine |
| Division name | The departent of geriatric medicine and nephrology |
| Address | 2-2, Yamadaoka, Suita, Osaka, Japan |
| TEL | 06-6879-3852 |
| itoh@geriat.med.osaka-u.ac.jp | |
| Public contact | |
| Name of contact person | Norihisa Ito |
| Organization | Osaka university graduate school of medicine |
| Division name | The departent of geriatric medicine and nephrology |
| Address | 2-2, Yamadaoka, Suita, Osaka, Japan |
| TEL | 06-6879-3852 |
| Homepage URL | |
| itoh@geriat.med.osaka-u.ac.jp | |
| Sponsor | |
| Institute | Osaka university graduate school of medicine
The departent of geriatric medicine and nephrology |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Osaka university graduate school of medicine
The departent of geriatric medicine and nephrology |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000018762 |